Give your SBIR Application an Edge by Including a Smart TABA Project

Federal Program Managers place increasing importance on the applicant's ability to commercialize. Under the SBIR/STTR Reauthorization Act, most federal agencies allow up to $6,500 in Phase 1 and $50,000 in Phase 2 for Technology and Business Assistance (TABA) — things like market research, financial modeling, commercialization planning, and regulatory strategy. Putting thought into the TABA project will inspire confidence in proposal reviewers.

What TABA Is Actually For

TABA is intended to fund the kind of strategic commercial work that turns a promising technology into a fundable new venture. That money doesn't reduce your R&D budget. It sits on top of it.

That means TABA is the right vehicle for:

• Primary market research — payer interviews, provider surveys, customer discovery
• Financial modeling — revenue forecasts, pricing analysis, commercialization pro formas
• Regulatory strategy — pathway analysis, reimbursement strategy, health economics frameworks
• Investor preparation — pitch deck support, data room structure, financial model documentation
• IP and licensing analysis — freedom-to-operate assessments, licensing strategy

What Scope Makes Sense for a Phase 1 TABA Project?

The best use of TABA for a Phase 1 award is to clarify one or more key business questions:

• What is the product or service? (detailed requirements)
• Who is the customer? Do they perceive a need for the product or service?
• What is the customer willing to pay for the product or service?
• Can the product or service be delivered profitably?

If you already have insights on these questions from customer discovery, think through your business using a lean canvas framework and choose an appropriate TABA vendor to help you shore up any open questions that remain. Don't forget that you can also use Phase 1 TABA funding to write the commercialization plan for your Phase 2 proposal.

How to Scope a Phase 2 TABA Project That Reviewers Fund

A Phase 2 TABA project should be used to prepare you for the best next step at the end of the R&D project. The difference between a funded and unfunded TABA section usually comes down to specificity. Reviewers want to see that you've thought carefully about what your company needs to reach the next value inflection — and that you have a credible plan to get there.

Strong TABA proposals answer three questions:

• What is the specific deliverable? Not "market research" — a structured analysis of reimbursement pathways for CPT codes 81479 and 81599 across Medicare and commercial payers, with primary interviews from 10 medical directors.
• How does it directly support commercialization? Show the reviewers the chain of logic: this analysis will inform our pricing strategy, which will ground our Series A financial model, which will support our fundraising process beginning in Q3 2026.
• Who is doing the work? Name your consultant or vendor if you have one. If not, describe the qualifications you'll require. Reviewers are skeptical of vague TABA budgets.

The business analysis performed in a TABA project could point to commercialization steps or could even clarify market requirements that reshape your R&D roadmap.

Look for Deliverables Your Team Actually Keeps

The best TABA engagements produce artifacts that outlive the grant period — models your team can update as assumptions change, analyses structured for your investor data room, frameworks your commercial team can execute against. That's what I build when I work with SBIR companies: financial models that are documented, assumption-transparent, and designed to be used by your team after the engagement ends.

If you're writing a Phase 2 proposal and haven't thought carefully about your TABA plan, it's worth the time. The projects can meaningfully change what your company looks like to investors and to SBIR reviewers.